Hormone Pregnancy Tests Alert Sample


Alert Sample

Alert results for: Hormone Pregnancy Tests

Information between 23rd September 2023 - 30th May 2024

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.


Parliamentary Debates
Business of the House
97 speeches (10,912 words)
Thursday 16th May 2024 - Commons Chamber
Leader of the House
Mentions:
1: Ian Mearns (Lab - Gateshead) The Committee has provisionally offered debates for that day on hormone pregnancy tests and the recognition - Link to Speech

Access to Redress Schemes
54 speeches (17,388 words)
Thursday 18th April 2024 - Commons Chamber
Cabinet Office
Mentions:
1: Christopher Chope (Con - Christchurch) Cumberlege report also recommended that discretionary schemes should be established for sodium valproate, hormone - Link to Speech



Select Committee Documents
Tuesday 19th March 2024
Oral Evidence - 2024-03-19 16:15:00+00:00

Proposals for backbench debates - Backbench Business Committee

Found: The first application is from Yasmin Qureshi and the all-party parliamentary group on hormone pregnancy

Wednesday 24th January 2024
Written Evidence - Patient Safety Commissioner
PSN0026 - Expert Panel: Evaluation of Government’s progress on meeting patient safety recommendations

Health and Social Care Committee

Found: Cumberlege and published on 8 July 2 020. 10.The IMMDS Review explored issues relating to the use of hormone

Tuesday 5th December 2023
Correspondence - Correspondence from the Parliamentary Under Secretary of State on the Committee's Expert Panel's evaluation on Patient Safety 27.11.23

Health and Social Care Committee

Found: the safety of treatments , specifically looking into cases of pelvic mesh , sodium valproate and hormone

Friday 1st December 2023
Minutes and decisions - Session 2022-23 List of Subjects Debated

Backbench Business Committee

Found: Tax-free Shopping for International Visitors Westminster Hall 0.5 38 61 (23) 7 September 2023 (1) Hormone

Thursday 26th October 2023
Formal Minutes - Session 2022-23 Formal Minutes

Backbench Business Committee

Found: • Sir Geoffrey Clifton- Brown: VAT reclaim on foreign shopping • Yasmin Qureshi, Hannah Bardell: Hormone



Written Answers
Hormone Pregnancy Tests Expert Working Group
Asked by: Yasmin Qureshi (Labour - Bolton South East)
Thursday 25th April 2024

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will make it her policy to commission an independent review of the Commission on Human Medicines’ Expert Working Group’s report on Hormone Pregnancy Tests.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered as a result of using Hormone Pregnancy Tests. We have no plans to set up an independent review to examine the findings of the Expert Working Group. In the interests of transparency, all evidence collected and papers considered by the Expert Working Group were published in 2018, along with full minutes of its discussions. Details of conflicts of interests, and how these were managed, were also published.

Primodos
Asked by: Dan Carden (Labour - Liverpool, Walton)
Tuesday 19th March 2024

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she plans to take steps to implement recommendations in the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered because of using Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group (EWG) conducted a comprehensive review of the available scientific evidence and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs and a possible causal association with adverse pregnancy outcomes.

On the recently published recommendations of the HPT All-Party Parliamentary Group, we have no plans to set up an independent review to examine the findings of the EWG. In the interests of transparency, all evidence collected and papers considered by the EWG were published in 2018, along with full minutes of its discussions. Details of conflicts of interests and how these were managed were also published. The Government is reviewing Professor Danielsson’s publication to consider if it presents any new evidence or analyses not already considered by the EWG on HPTs, and will be seeking independent expert advice from the Commission on Human Medicines in due course.

Primodos
Asked by: Jeff Smith (Labour - Manchester, Withington)
Thursday 14th March 2024

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential implications for her Department’s policies of the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered due to the use of Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group conducted a comprehensive review of the available scientific evidence, and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs, and a possible causal association with adverse pregnancy outcomes.

Primodos
Asked by: Jeff Smith (Labour - Manchester, Withington)
Thursday 14th March 2024

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will implement the recommendations in the report by the APPG on Hormone Pregnancy Test entitled Bitter Pill: Primodos - the forgotten thalidomide, published on 27 February 2024.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

We remain hugely sympathetic to the families who believe that they have suffered due to the use of Hormone Pregnancy Tests (HPTs). In 2017 an independent Expert Working Group conducted a comprehensive review of the available scientific evidence, and concluded that the data did not support a causal association between the use of HPTs, such as Primodos, and adverse pregnancy outcomes. This remains the Government’s position. The Government has committed to reviewing any new evidence related to HPTs, and a possible causal association with adverse pregnancy outcomes.

Primodos: Compensation
Asked by: Gavin Williamson (Conservative - South Staffordshire)
Monday 25th September 2023

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to take steps to secure financial redress for the victims of Primodos.

Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)

The Government published its response to the Independent Medicines and Medical Devices Safety (IMMDS) review in July 2021, which did not accept the recommendation to establish separate redress schemes for the three interventions covered by the review. This included a redress scheme for those harmed by Primodos.

Our priority is to make medicines and devices safer, and the Government is pursuing a wide range of activity to further this aim. The 2021 response, and the Government’s December 2022 update to the response, explains the changes that have been put in place since the IMMDS Review report’s publication, and the further action the Government will take to implement the recommendations accepted and to improve patient safety.

In the recent House of Commons debate of 7 September 2023 on hormone pregnancy tests, I committed to review the outstanding recommendations in relation to Primodos.



Non-Departmental Publications - Transparency
Mar. 14 2024
Medicines and Healthcare products Regulatory Agency
Source Page: Freedom of Information responses from the MHRA - week commencing 4 December 2023
Document: FOI 23/923 (PDF)
Transparency

Found: request, dated November 21st 2023 , where you asked for information about how the call for evidence on Hormone




Hormone Pregnancy Tests mentioned in Scottish results


Scottish Select Committee Publications
Wednesday 28th February 2024
Correspondence - Letter from Minister for Public Health and Women's Health to HCSC Convener, 28 February 2024
Hughes report about redress options to Valproate and Pelvic Mesh

Health, Social Care and Sport Committee

Found: also stated that t hey will review any new scientific evidence which may come to light in relation to hormone



Scottish Parliamentary Debates
Patient Safety Commissioner for Scotland Bill: Stage 3
129 speeches (143,516 words)
Wednesday 27th September 2023 - Main Chamber
Mentions:
1: Sweeney, Paul (Lab - Glasgow) Marie Lyon, from the Association for Children Damaged by Hormone Pregnancy Tests, told the Health, Social - Link to Speech

Patient Safety Commissioner for Scotland Bill: Stage 3
23 speeches (63,710 words)
Wednesday 27th September 2023 - Main Chamber
Mentions:
1: Sweeney, Paul (Lab - Glasgow) egregiously in some cases, including in the cases of women who were impacted by transvaginal mesh and hormone - Link to Speech